Hypercalcemic nephropathy.
Benabe JE, Martinez-Maldonado M.
Arch Intern Med. 1978 May;138(5):777-9.
Familial hypocalciuric hypercalcemia and related disorders.
Lee JY, Shoback DM.
Best Pract Res Clin Endocrinol Metab. 2018 Oct;32(5):609-619. doi: 10.1016/j.beem.2018.05.004. Epub 2018 May 26.
[Hypercalcemic nephropathy].
Makino H, Kawabata K, Mimura Y.
Ryoikibetsu Shokogun Shirizu. 1997;(17 Pt 2):193-6.
Hypercalcemic nephropathy.
NASH DT, SCHWARTZ BM.
J Mt Sinai Hosp N Y. 1958 Sep-Oct;25(5):458-63.
Normocalcemic Hyperparathyroidism.
Corbetta S.
Front Horm Res. 2019;51:23-39. doi: 10.1159/000491036. Epub 2018 Nov 19.
HYPERCALCAEMIC NEPHROPATHY.
PARFITT AM.
Med J Aust. 1964 Jul 25;2:127-34. doi: 10.5694/j.1326-5377.1964.tb115035.x.
[Hypercalcemic crisis and hypocalcemic tetany].
Kasperk C.
Internist (Berl). 2017 Oct;58(10):1029-1036. doi: 10.1007/s00108-017-0311-3.
[Hypercalcemic nephropathy].
MORTENSEN ES.
Ugeskr Laeger. 1961 Jun 16;123:833-8.
Comparison of Normocalcemic vs Hypercalcemic Primary Hyperparathyroidism in a Hypercalciuric Renal Stone Population.
Halimi C, Bor C, Chieze R, Saint-Jacques C, Périé S, Wagner I, Talbot JN, Montravers F, Letavernier E, Buob D, Daudon M, Frochot V, Haymann JP.
J Clin Endocrinol Metab. 2024 Sep 16;109(10):2553-2560. doi: 10.1210/clinem/dgae162.
Secondary and Tertiary Hyperparathyroidism.
Messa P, Alfieri CM.
Front Horm Res. 2019;51:91-108. doi: 10.1159/000491041. Epub 2018 Nov 19.
